Divis Laboratories Ltd | DIVI - Assets


Divis Laboratories Ltd reported INR200.33B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alaunos Therapeutics USD 1.52M 367K Jun/2026
Aurobindo Pharma INR 585.02B 59.57B Mar/2026
Avita Medical AUD 47.78M 8.62M Jun/2026
Dianthus Therapeutics USD 1.21B 33.61M Jun/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Lupin INR 383.65B 48.64B Mar/2026
Moderna USD 10.96B 527M Jun/2026
Organon & Co USD 13.4B 223M Sep/2026
Revvity USD 12.05B 49.24M Jun/2026
Tectonic Therapeutic USD 237.03M 9.54M Jun/2026
Tilray USD 2.1B 15.95M Sep/2025
Viatris USD 35.04B 1.79B Jun/2026
Xeris Pharmaceuticals USD 411.9M 19.89M Jun/2026